Matches in Wikidata for { <http://www.wikidata.org/entity/Q64804153> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q64804153 description "assaig clínic" @default.
- Q64804153 description "clinical trial" @default.
- Q64804153 description "clinical trial" @default.
- Q64804153 description "clinical trial" @default.
- Q64804153 description "clinical trial" @default.
- Q64804153 description "ensaio clínico" @default.
- Q64804153 description "ensayo clínico" @default.
- Q64804153 description "ensayu clínicu" @default.
- Q64804153 description "essai clinique" @default.
- Q64804153 description "klinisch onderzoek" @default.
- Q64804153 description "клінічне випробування" @default.
- Q64804153 name "Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr" @default.
- Q64804153 type Item @default.
- Q64804153 label "Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr" @default.
- Q64804153 prefLabel "Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr" @default.
- Q64804153 P1132 Q64804153-AA7DAB33-9D03-43C4-BC78-8C927AA95295 @default.
- Q64804153 P1476 Q64804153-393CE6DA-12F7-4858-85B0-246221BEC7CB @default.
- Q64804153 P17 Q64804153-E8B11435-0B88-484B-8735-3D1FDE2D1187 @default.
- Q64804153 P1813 Q64804153-5C2EE827-BD2F-4702-8CD7-7C1E3F94035D @default.
- Q64804153 P2899 Q64804153-F7F65DAC-E7BA-4110-888D-6CA8CAA99C53 @default.
- Q64804153 P3098 Q64804153-31ED741D-05B9-48C5-82F1-46A48704756D @default.
- Q64804153 P31 Q64804153-A00F4A18-35E2-483C-B5D4-7BACE7240EA2 @default.
- Q64804153 P4135 Q64804153-E1C135CE-6A35-451F-950C-D47352F2BD27 @default.
- Q64804153 P580 Q64804153-61CF622B-20F9-4F09-9B86-CC3FDF1644B5 @default.
- Q64804153 P582 Q64804153-A8D4DF00-0028-42DB-9338-10B4ADC792D3 @default.
- Q64804153 P6099 Q64804153-5BE3236F-40BF-4CDC-9CFC-3B46C5843CDE @default.
- Q64804153 P6153 Q64804153-98C7D0E7-384F-43FA-8503-0994FA701F6D @default.
- Q64804153 P6153 Q64804153-DC3F65EA-46E8-45FF-ADD4-20B163C33D2D @default.
- Q64804153 P8363 Q64804153-91E49A3E-D095-45C9-B545-119822E52418 @default.
- Q64804153 P1132 "+1360" @default.
- Q64804153 P1476 "A Randomized Phase 3 Trial Comparing Continuation Nivolumab-Ipilimumab Doublet Immunotherapy Until Progression Versus Observation in Treatment-naive Patients With PDL1-positive Stage IV Non-Small Cell Lung Cancer (NSCLC) After Nivolumab-Ipilimumab Induction Treatment" @default.
- Q64804153 P17 Q142 @default.
- Q64804153 P1813 "DICIPLE" @default.
- Q64804153 P2899 "+18" @default.
- Q64804153 P3098 "NCT03469960" @default.
- Q64804153 P31 Q30612 @default.
- Q64804153 P4135 "+75" @default.
- Q64804153 P580 "2018-05-02T00:00:00Z" @default.
- Q64804153 P582 "2023-05-01T00:00:00Z" @default.
- Q64804153 P6099 Q42824827 @default.
- Q64804153 P6153 Q2945741 @default.
- Q64804153 P6153 Q2945774 @default.
- Q64804153 P8363 Q78089383 @default.